ALEXIS HLAVACH: Open Payments
NPI 1790032464 · UNIVERSITY PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 36 payments from 12 companies in 2025. Trend: 2023 $583 · 2024 $705 · 2025 $717
Food & beverage: $674Education: $43
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $161 |
| Organon LLC | 3 | $110 |
| UCB, Inc. | 2 | $67 |
| Janssen Biotech, Inc. | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $60 |
| Lilly USA, LLC | 2 | $54 |
| Incyte Corporation | 2 | $47 |
| ABBVIE INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
Products named: VTAMA, NEMLUVIO, Bimzelx, TREMFYA, TALTZ, OPZELURA, SKYRIZI, SPEVIGO.
Industry payments across FL — which companies pay providers there.
